DPP3 (Procizumab Biosimilar) Recombinant Monoclonal Antibody

Code CSB-RA868352MB1HU
Size US$9799
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
Alternative Names
AK-1967 research-grade biosimilar; PCZ research-grade biosimilar ;DPP3 antibody; Dipeptidyl peptidase 3 antibody; EC 3.4.14.4 antibody; Dipeptidyl aminopeptidase III antibody; Dipeptidyl arylamidase III antibody; Dipeptidyl peptidase III antibody; DPP III antibody; Enkephalinase B antibody
Species Reactivity
Human
Immunogen
Recombinant Human DPP3 protein
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Clonality
Monoclonal
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
0.01M PBS,pH7.4
Form
Liquid
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Notes
Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity > 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.
Lead Time
3-4 weeks
Description

This recombinant monoclonal antibody is designed as a research-grade biosimilar to Procizumab, targeting dipeptidyl peptidase 3 (DPP3), a cytosolic metallopeptidase involved in the degradation of bioactive peptides. DPP3 plays a critical role in cardiovascular physiology by cleaving angiotensin II and other vasoactive peptides, thereby modulating blood pressure regulation and cardiac function. Elevated circulating DPP3 levels have been associated with acute circulatory failure, cardiogenic shock, and increased mortality in critically ill patients, making it an important biomarker and potential therapeutic target in cardiovascular medicine and critical care research.

Procizumab represents a novel therapeutic approach under clinical investigation for the treatment of cardiogenic shock and acute heart failure, functioning by neutralizing circulating DPP3 to restore hemodynamic stability. This biosimilar antibody provides researchers with a valuable tool for investigating DPP3-mediated pathways, exploring cardiovascular disease mechanisms, and conducting preclinical studies related to shock states and cardiac dysfunction. It enables the study of DPP3 biology and validation of therapeutic strategies targeting this emerging cardiovascular mediator.

Usage
It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Cleaves and degrades bioactive peptides, including angiotensin, Leu-enkephalin and Met-enkephalin. Also cleaves Arg-Arg-beta-naphthylamide (in vitro).
Gene References into Functions
  1. We conclude that DPP 3 may influence the cellular expression of Ang-(1-7) and potentially reflect a therapeutic target to augment the actions of the peptide PMID: 27315786
  2. biological function of human dipeptidyl peptidase III PMID: 26887037
  3. several crystal structures of complexes of human dipeptidyl peptidase III with different peptides. PMID: 27025154
  4. Evidence for concurrent expression of hDPP III mRNA V-I and V-II in multiple human tumor derived cell lines. PMID: 27153830
  5. the DPP III conformational landscape and the influence of ligand binding on the protein structure and dynamics, was investigated. PMID: 26334575
  6. Kinetic studies revealed that the single mutant D496G lost selectivity due to the increase of the Km value. The D496G, but not S504G, showed significantly decreased binding of peptides with N-terminal arginine, and of tynorphin. PMID: 25581752
  7. The study used three different conformations of human dipeptidyl-peptidase III (DPP III) to investigate the influence of the protein environment on ligand binding and the Zn(2+) coordination. PMID: 25192149
  8. Deletion/mutagenesis of C/EBP-beta binding motif of DPP III promoter significantly increased its activity and abolished its responsiveness to IL-6 in glioblastoma cells. PMID: 24472318
  9. The activity of the yeast and human dipeptidyl peptidase III were examined. PMID: 23362197
  10. Combined results of mutational analysis and mass spectrometry suggest that glutathionylation (formation of mixed disulfide) of Cys176 and Cys654 contributes to human DPP III inactivation by oxidized glutathione. PMID: 23667907
  11. Amplification and mRNA overexpression of the DPP3 gene is associated with squamous cell lung carcinomas. PMID: 23382044
  12. results provide the basis for the design of specific inhibitors that enable the elucidation of the exact role of DPP III and the exploration of its potential as a target of pain intervention strategies PMID: 22493238
  13. Ets-1/Elk-1 is a critical mediator of DPP3 transcription in human glioblastoma cells. PMID: 20236318
  14. In malignant neoplasms of the ovary DPP III activity increased with growing histologic grade. PMID: 14529681
  15. the conserved tyrosine could be involved in transition state stabilization during the catalytic action of M49 peptidases. PMID: 18163885

Show More

Hide All

Subcellular Location
Cytoplasm, cytosol.
Protein Families
Peptidase M49 family
Tissue Specificity
Detected in placenta (at protein level). Detected in erythrocytes (at protein level).
Database Links

HGNC: 3008

OMIM: 606818

KEGG: hsa:10072

STRING: 9606.ENSP00000353701

UniGene: Hs.502914

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2026 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*